✦ LIBER ✦

Testoterone kinetics after androgen-deprivation therapy in intermediate and high risk prostate cancer: Results from a randomized trial (DART01/05)

✍ Scribed by González-san Segundo, C.; Zapatero, A.; Guerrero, A.; Maldonado, X.; Álvarez, A.; Cabeza, M.; Macías, V.; Casas, F.; Pedro-olivé, A.; Boladeras, A.; Martín de Vidales, C.; Vázquez, M.; Calvo, F.

Book ID: 122928392
Publisher: Wielkopolskie Centrum Onkologii
Year: 2013
Tongue: Polish
Weight: 65 KB
Volume: 18
Category: Article
ISSN: 1507-1367
DOI: 10.1016/j.rpor.2013.03.824

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Late Side Effects in Men With Intermedia

Late Side Effects in Men With Intermediate- and High-Risk Prostate Cancer Treated With High-Dose Radiation Therapy and Androgen Deprivation (DART 01/05): Secondary Endpoints From a Phase 3 Clinical Trial

✍ Zapatero, A.; Guerrero, A.; Maldonado, X.; Alvarez, A.; Gonzalez San Segundo, C. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Long-term vs. Short-term Androgen Depriv

Long-term vs. Short-term Androgen Deprivation Combined with High-dose Radiotherapy for Intermediate and High-risk Prostate Cancer: Preliminary Results of a GICOR Phase III Randomized Trial

✍ A. Zapatero; A. Guerrero; X. Maldonado; A. Alvarez; A. Cabeza; C. Gonzalez San S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Neoadjuvant Androgen Deprivation Therapy

Neoadjuvant Androgen Deprivation Therapy for Prostate Volume Reduction, Lower Urinary Tract Symptom Relief and Quality of Life Improvement in Men with Intermediate- to High-risk Prostate Cancer: A Randomised Non-inferiority Trial of Degarelix versus Goserelin plus Bicalutamide

✍ Mason, M.; Maldonado Pijoan, X.; Steidle, C.; Guerif, S.; Wiegel, T.; van der Me 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 401 KB